XML 130 R88.htm IDEA: XBRL DOCUMENT
v2.4.1.9

14. SEGMENTS (Details 1) (USD $) | 3 Months Ended | 6 Months Ended | 12 Months Ended |
--- | --- | --- | --- | ---
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2012
Total Revenues | $ 479,075 us-gaap_Revenues | $ 644,887 us-gaap_Revenues | $ 530,371 us-gaap_Revenues | $ 840,483 us-gaap_Revenues | $ 1,623,769 us-gaap_Revenues | $ 1,230,004 us-gaap_Revenues |
Total Operating Loss | (601,192)us-gaap_OperatingIncomeLoss | (229,796)us-gaap_OperatingIncomeLoss | (1,773,200)us-gaap_OperatingIncomeLoss | (1,013,592)us-gaap_OperatingIncomeLoss | (3,055,928)us-gaap_OperatingIncomeLoss | (3,575,354)us-gaap_OperatingIncomeLoss |
Net Loss | (847,409)us-gaap_NetIncomeLoss | (3,349,670)us-gaap_NetIncomeLoss | (4,503,350)us-gaap_NetIncomeLoss | (3,653,168)us-gaap_NetIncomeLoss | (13,357,232)us-gaap_NetIncomeLoss | (4,892,040)us-gaap_NetIncomeLoss |
Total Assets | 1,089,269 us-gaap_Assets | 411,190 us-gaap_Assets | 1,089,269 us-gaap_Assets | 411,190 us-gaap_Assets | 1,695,102 us-gaap_Assets | 496,694 us-gaap_Assets |
Total Cash | 526,187 us-gaap_Cash | 8,754 us-gaap_Cash | 526,187 us-gaap_Cash | 8,754 us-gaap_Cash | 1,250,279 us-gaap_Cash | 125,274 us-gaap_Cash | 143,907 us-gaap_Cash
Capital Expenditures |  |  | 0 us-gaap_NetCashProvidedByUsedInInvestingActivities | 0 us-gaap_NetCashProvidedByUsedInInvestingActivities | (96,056)us-gaap_NetCashProvidedByUsedInInvestingActivities | 0 us-gaap_NetCashProvidedByUsedInInvestingActivities |
Total Depreciation and Amortization |  |  | 18,676 us-gaap_DepreciationDepletionAndAmortization | 4,727 us-gaap_DepreciationDepletionAndAmortization | 21,087 us-gaap_DepreciationDepletionAndAmortization | 10,484 us-gaap_DepreciationDepletionAndAmortization |
Total Interest Expense | (78,145)us-gaap_InterestAndDebtExpense | (110,405)us-gaap_InterestAndDebtExpense | (144,799)us-gaap_InterestAndDebtExpense | (216,443)us-gaap_InterestAndDebtExpense | (1,287,221)us-gaap_InterestAndDebtExpense | (1,132,314)us-gaap_InterestAndDebtExpense |
Aethlon Medical, Inc [Member] |  |  |  |  |  |  |
Total Revenues |  |  |  |  | 1,623,769 us-gaap_Revenues / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember | 1,230,004 us-gaap_Revenues / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember |
Total Operating Loss |  |  |  |  | (2,651,863)us-gaap_OperatingIncomeLoss / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember | (3,575,354)us-gaap_OperatingIncomeLoss / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember |
Net Loss |  |  |  |  | (13,357,232)us-gaap_NetIncomeLoss / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember | (4,892,040)us-gaap_NetIncomeLoss / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember |
Total Assets |  |  |  |  | 597,026 us-gaap_Assets / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember | 496,694 us-gaap_Assets / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember |
Total Cash |  |  |  |  | 208,259 us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember | 125,274 us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember |
Capital Expenditures |  |  |  |  | 37,313 us-gaap_NetCashProvidedByUsedInInvestingActivities / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember | 0 us-gaap_NetCashProvidedByUsedInInvestingActivities / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember |
Total Depreciation and Amortization |  |  |  |  | 11,549 us-gaap_DepreciationDepletionAndAmortization / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember | 10,484 us-gaap_DepreciationDepletionAndAmortization / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember |
Total Interest Expense |  |  |  |  | (1,282,638)us-gaap_InterestAndDebtExpense / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember | (1,132,314)us-gaap_InterestAndDebtExpense / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_AethlonMedicalIncMember |
Exosome Sciences, Inc [Member] |  |  |  |  |  |  |
Total Revenues |  |  |  |  | 0 us-gaap_Revenues / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember | 0 us-gaap_Revenues / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember |
Total Operating Loss |  |  |  |  | (404,065)us-gaap_OperatingIncomeLoss / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember | 0 us-gaap_OperatingIncomeLoss / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember |
Net Loss |  |  |  |  | (81,730)us-gaap_NetIncomeLoss / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember | 0 us-gaap_NetIncomeLoss / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember |
Total Assets |  |  |  |  | 1,098,076 us-gaap_Assets / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember | 0 us-gaap_Assets / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember |
Total Cash |  |  |  |  | 1,042,020 us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember | 0 us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember |
Capital Expenditures |  |  |  |  | 58,743 us-gaap_NetCashProvidedByUsedInInvestingActivities / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember | 0 us-gaap_NetCashProvidedByUsedInInvestingActivities / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember |
Total Depreciation and Amortization |  |  |  |  | 9,538 us-gaap_DepreciationDepletionAndAmortization / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember | 0 us-gaap_DepreciationDepletionAndAmortization / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember |
Total Interest Expense |  |  |  |  | $ (4,583)us-gaap_InterestAndDebtExpense / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember | $ 0 us-gaap_InterestAndDebtExpense / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aemd_ExosomeSciencesIncMember |

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_Cash
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 + Details
Name: | us-gaap_InterestAndDebtExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 + Details
Name: | us-gaap_NetCashProvidedByUsedInInvestingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aemd_AethlonMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aemd_ExosomeSciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |